Yu HJ, Thijssen E, van Brummelen E, van der Plas JL, Radanovic I, Moerland M, Hsieh E, Groeneveld GJ, Dodart JC. A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine. Mov Disord. 2022 Jul;37(7):1416-1424. Epub 2022 Apr 15 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. UB-312 Synuclein Vaccine Safe in Controls. Next Up: Parkinson's.

Therapeutics

  1. UB-312